SAB Biotherapeutics Warrant
SABSW
SABSW
16 hedge funds and large institutions have $383K invested in SAB Biotherapeutics Warrant in 2022 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 4 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
56% less capital invested
Capital invested by funds: $863K → $383K (-$480K)
Holders
16
Holding in Top 10
–
Calls
$177K
Puts
–
Top Buyers
| 1 | +$3.49K | |
| 2 | +$1.4K | |
| 3 | +$669 | |
| 4 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
+$193 |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$142 |
Top Sellers
| 1 | -$19.2K | |
| 2 | -$2.16K | |
| 3 | -$2K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$2K |
| 5 |
Jane Street
New York
|
-$10 |